Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
NCT ID: NCT00960908
Last Updated: 2009-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators will compare 2nd generation ZE (Endeavor resolute, active prospective arm) with 1st generation ZES (Endeavor Sprint, retrospective arm).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )
NCT01365572
Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents
NCT03507205
BES, EES, and ZES-R in Real World Practice
NCT01397175
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV)
NCT01186094
The Medtronic RESOLUTE Clinical Trial
NCT00248079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Resolute
Prospective recruitment of Resolute arm will start in March 2009
Endeavor Resolute stents
2nd generation ZES
Endeavor
The retrospective recruiting period of Endeavor arm comprises a fixed 2-year time between January 2006 and December 2008. The patients, who were treated with Endeavor in that period, will be enrolled if they agree to participate in this study.
Endeavor Sprint stent
1st generation ZES
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endeavor Resolute stents
2nd generation ZES
Endeavor Sprint stent
1st generation ZES
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Alternatively, a legally authorized patient representative may agree to the patient's participation in this study and sign the informed consent form.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seoul National University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyo-Soo Kim, MD, PhD
Role: STUDY_CHAIR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hallym University Sacred Heart Hospital
Anyang, , South Korea
Yongnam University Medical Center
Daegu, , South Korea
Chungnam National University Hospital
Daejeon, , South Korea
Chonbuk National Univesity Hospital
Iksan, , South Korea
Inje University Ilsan Paik Hospital
Ilsan, , South Korea
National Health Insurance Corporation Ilsan Hospital
Ilsan, , South Korea
Gachon Kil Medical Center
Inchon, , South Korea
Inha University Hospital
Inchon, , South Korea
Gyeongsang National University Hospital
Jinju, , South Korea
Pusan National University Hospital
Pusan, , South Korea
Bundang CHA Medical Center
Seongnam, , South Korea
Seoul National University Bundang Hospital
Seongnam, , South Korea
Gangbuk Samsung Hospital
Seoul, , South Korea
Kangdong Sacred Heart Hospital
Seoul, , South Korea
Seoul Boramae Hospital
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Soonchunhyang University Hospital
Seoul, , South Korea
St. Vincent's Hospital
Suwon, , South Korea
Uijeongbu St. Mary's Hospital
Uijeongbu-si, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RESOLUTE-KOREA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.